Note any changes in appetite, energy levels, or digestive patterns
Death from CV cause, nonfatal MI or stroke occurred in 8% of the placebo group and 6.5 % of the treatment groupso the absolute risk of events was reduced by 1.5%
[1] [4] Additionally, GLP-1 receptors are present in areas of the brain involved in nausea and appetite regulation, particularly the area postrema in the brainstem
Approved April 2026
Acknowledgements We are in debt to the SBD Central Commitee members: Adriana Costa e Forti, Bianca Pittito, Lenita Zajdenverg, Melanie Rodacki, Joaquim Custdio, Luis Eduardo Calliari, Renan Montenegro, Fernando Valente, Laerte Damaceno, Rodrigo Lamounier, Srgio Vencio, Sherida Paz de Oliveira, Silvia Ramos, Fani Malerbi, Denise Vancea and especially to the SBD President Domingos Malerbi, who made possible this initiative